Page last updated: 2024-10-29

staurosporine aglycone and Peripheral Nerve Diseases

staurosporine aglycone has been researched along with Peripheral Nerve Diseases in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Research Excerpts

ExcerptRelevanceReference
"Many drugs approved for neuropathic pain engage spinal noradrenergic and cholinergic systems for analgesia."1.37A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury. ( Eisenach, JC; Hayashida, K, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashida, K1
Eisenach, JC1

Other Studies

1 other study available for staurosporine aglycone and Peripheral Nerve Diseases

ArticleYear
A tropomyosine receptor kinase inhibitor blocks spinal neuroplasticity essential for the anti-hypersensitivity effects of gabapentin and clonidine in rats with peripheral nerve injury.
    The journal of pain, 2011, Volume: 12, Issue:1

    Topics: Acetylcholine; Amines; Analgesics; Animals; Carbazoles; Choline O-Acetyltransferase; Clonidine; Cycl

2011